Search
  1. Home
  2. West Africa
  3. Nigeria

Drug giant slashes antiretroviral prices

    JOHANNESBURG
    Pharmaceutical giant GlaxoSmithKline (GSK) has announced a further price reduction across its full range of HIV/AIDS drugs in Nigeria. The company said its "preferential pricing programme" was aimed at ensuring that people living with HIV/AIDS had adequate access to the best drugs available, irrespective of their economic status. The drugs were currently available to NGOs, UN agencies, military establishments, and employers offering treatment and care to their staff at designated centres in different parts of the country. Organisations wanting to be part of the GSK programme were urged to contact the company's HIV/AIDS manager. The local Vanguard newspaper quoted GSK’s HIV/AIDS manager, Folake Adeniji, as saying: "Anyone with symptoms of HIV or AIDS should seek early medical care at the designated centres, so that they can benefit from the price reduction."

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join